Report Detail
Global Recombinant Vaccines Market Research Report 2019
- RnM3192056 |
- 26 March, 2019 |
- Global |
- 98 Pages |
- QYResearch |
- Pharma & Healthcare
Recombinant vaccines are produced using recombinant DNA technology, with the help of a vector. These vaccines stimulate the immune system of an individual and provide immunity against various lethal disease.
These vaccines are safe and have less or no side-effects as compared to conventional vaccines, in the prevention of various diseases such as influenza, cholera, typhoid, and dengue.
Recombinant vaccines are also used in animals for prevention of diseases such as foot and mouth disease, pneumonia and septicemia, and pox disease. Vaccination results in the prevention of disease, by producing antibodies against the protein antigen of pathogenic microorganisms.
There is increase in the demand for livestock products, which in turn has increased growth of the animal recombinant vaccine segment and Europe dominates the animal recombinant vaccines market as compared to other regions due to highly organized livestock and huge demand of livestock product for the European population.
The global Recombinant Vaccines market is valued at 880 million US$ in 2018 is expected to reach 1400 million US$ by the end of 2025, growing at a CAGR of 6.0% during 2019-2025.
This report focuses on Recombinant Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Vaccines market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Merck & Co., Inc
Green Cross Corporation
Pfizer Inc.
Bayer AG
Sanofi S A.
Protein Science Corporation
GlaxoSmithKline Plc.
Novartis AG
Bharat Biotech
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Segment by Application
Recombinant Human Vaccines
Animal Recombinant Vaccines
Table of Contents
Executive Summary
1 Recombinant Vaccines Market Overview
- 1.1 Product Overview and Scope of Recombinant Vaccines
- 1.2 Recombinant Vaccines Segment by Type
- 1.2.1 Global Recombinant Vaccines Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Subunit Recombinant Vaccines
- 1.2.3 Attenuated Recombinant Vaccines
- 1.2.4 Vector Recombinant Vaccines
- 1.3 Recombinant Vaccines Segment by Application
- 1.3.1 Recombinant Vaccines Consumption Comparison by Application (2014-2025)
- 1.3.2 Recombinant Human Vaccines
- 1.3.3 Animal Recombinant Vaccines
- 1.4 Global Recombinant Vaccines Market by Region
- 1.4.1 Global Recombinant Vaccines Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Recombinant Vaccines Market Size
- 1.5.1 Global Recombinant Vaccines Revenue (2014-2025)
- 1.5.2 Global Recombinant Vaccines Production (2014-2025)
2 Global Recombinant Vaccines Market Competition by Manufacturers
- 2.1 Global Recombinant Vaccines Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Recombinant Vaccines Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Recombinant Vaccines Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Recombinant Vaccines Production Sites, Area Served, Product Types
- 2.5 Recombinant Vaccines Market Competitive Situation and Trends
- 2.5.1 Recombinant Vaccines Market Concentration Rate
- 2.5.2 Recombinant Vaccines Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Recombinant Vaccines Production Market Share by Regions
- 3.1 Global Recombinant Vaccines Production Market Share by Regions
- 3.2 Global Recombinant Vaccines Revenue Market Share by Regions (2014-2019)
- 3.3 Global Recombinant Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Recombinant Vaccines Production
- 3.4.1 North America Recombinant Vaccines Production Growth Rate (2014-2019)
- 3.4.2 North America Recombinant Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Recombinant Vaccines Production
- 3.5.1 Europe Recombinant Vaccines Production Growth Rate (2014-2019)
- 3.5.2 Europe Recombinant Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Recombinant Vaccines Production (2014-2019)
- 3.6.1 China Recombinant Vaccines Production Growth Rate (2014-2019)
- 3.6.2 China Recombinant Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Recombinant Vaccines Production (2014-2019)
- 3.7.1 Japan Recombinant Vaccines Production Growth Rate (2014-2019)
- 3.7.2 Japan Recombinant Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Recombinant Vaccines Consumption by Regions
- 4.1 Global Recombinant Vaccines Consumption by Regions
- 4.2 North America Recombinant Vaccines Consumption (2014-2019)
- 4.3 Europe Recombinant Vaccines Consumption (2014-2019)
- 4.4 China Recombinant Vaccines Consumption (2014-2019)
- 4.5 Japan Recombinant Vaccines Consumption (2014-2019)
5 Global Recombinant Vaccines Production, Revenue, Price Trend by Type
- 5.1 Global Recombinant Vaccines Production Market Share by Type (2014-2019)
- 5.2 Global Recombinant Vaccines Revenue Market Share by Type (2014-2019)
- 5.3 Global Recombinant Vaccines Price by Type (2014-2019)
- 5.4 Global Recombinant Vaccines Production Growth by Type (2014-2019)
6 Global Recombinant Vaccines Market Analysis by Applications
- 6.1 Global Recombinant Vaccines Consumption Market Share by Application (2014-2019)
- 6.2 Global Recombinant Vaccines Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Recombinant Vaccines Business
- 7.1 Merck & Co., Inc
- 7.1.1 Merck & Co., Inc Recombinant Vaccines Production Sites and Area Served
- 7.1.2 Recombinant Vaccines Product Introduction, Application and Specification
- 7.1.3 Merck & Co., Inc Recombinant Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Green Cross Corporation
- 7.2.1 Green Cross Corporation Recombinant Vaccines Production Sites and Area Served
- 7.2.2 Recombinant Vaccines Product Introduction, Application and Specification
- 7.2.3 Green Cross Corporation Recombinant Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Pfizer Inc.
- 7.3.1 Pfizer Inc. Recombinant Vaccines Production Sites and Area Served
- 7.3.2 Recombinant Vaccines Product Introduction, Application and Specification
- 7.3.3 Pfizer Inc. Recombinant Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Bayer AG
- 7.4.1 Bayer AG Recombinant Vaccines Production Sites and Area Served
- 7.4.2 Recombinant Vaccines Product Introduction, Application and Specification
- 7.4.3 Bayer AG Recombinant Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Sanofi S A.
- 7.5.1 Sanofi S A. Recombinant Vaccines Production Sites and Area Served
- 7.5.2 Recombinant Vaccines Product Introduction, Application and Specification
- 7.5.3 Sanofi S A. Recombinant Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Protein Science Corporation
- 7.6.1 Protein Science Corporation Recombinant Vaccines Production Sites and Area Served
- 7.6.2 Recombinant Vaccines Product Introduction, Application and Specification
- 7.6.3 Protein Science Corporation Recombinant Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 GlaxoSmithKline Plc.
- 7.7.1 GlaxoSmithKline Plc. Recombinant Vaccines Production Sites and Area Served
- 7.7.2 Recombinant Vaccines Product Introduction, Application and Specification
- 7.7.3 GlaxoSmithKline Plc. Recombinant Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Novartis AG
- 7.8.1 Novartis AG Recombinant Vaccines Production Sites and Area Served
- 7.8.2 Recombinant Vaccines Product Introduction, Application and Specification
- 7.8.3 Novartis AG Recombinant Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Bharat Biotech
- 7.9.1 Bharat Biotech Recombinant Vaccines Production Sites and Area Served
- 7.9.2 Recombinant Vaccines Product Introduction, Application and Specification
- 7.9.3 Bharat Biotech Recombinant Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
8 Recombinant Vaccines Manufacturing Cost Analysis
- 8.1 Recombinant Vaccines Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Recombinant Vaccines
- 8.4 Recombinant Vaccines Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Recombinant Vaccines Distributors List
- 9.3 Recombinant Vaccines Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Recombinant Vaccines Market Forecast
- 11.1 Global Recombinant Vaccines Production, Revenue Forecast
- 11.1.1 Global Recombinant Vaccines Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Recombinant Vaccines Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Recombinant Vaccines Price and Trend Forecast (2019-2025)
- 11.2 Global Recombinant Vaccines Production Forecast by Regions (2019-2025)
- 11.2.1 North America Recombinant Vaccines Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Recombinant Vaccines Production, Revenue Forecast (2019-2025)
- 11.2.3 China Recombinant Vaccines Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Recombinant Vaccines Production, Revenue Forecast (2019-2025)
- 11.3 Global Recombinant Vaccines Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Recombinant Vaccines Consumption Forecast (2019-2025)
- 11.3.2 Europe Recombinant Vaccines Consumption Forecast (2019-2025)
- 11.3.3 China Recombinant Vaccines Consumption Forecast (2019-2025)
- 11.3.4 Japan Recombinant Vaccines Consumption Forecast (2019-2025)
- 11.4 Global Recombinant Vaccines Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Recombinant Vaccines Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Recombinant Vaccines . Industry analysis & Market Report on Recombinant Vaccines is a syndicated market report, published as Global Recombinant Vaccines Market Research Report 2019. It is complete Research Study and Industry Analysis of Recombinant Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
